Cargando...
Dyskinesias as a limiting factor in the treatment of Segawa disease
Patients with autosomal dominant Segawa disease (dopa-responsive dystonia) show an excellent and sustained response to small doses of levodopa. In contrast, the development of levodopa limiting treatment dyskinesias is thought to support the diagnosis of other early onset dystonia/parkinsonism syndr...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2012
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3361688/ https://ncbi.nlm.nih.gov/pubmed/22633640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pediatrneurol.2012.03.003 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|